Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

202
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
202
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

174
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
174
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

163
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
163
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

160
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
160
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Depressants01:28

Depressants

99
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
99

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Hippocampal subfields volumes and affective symptoms of patients with mesial temporal lobe epilepsy.

Epilepsy & behavior : E&B·2025
Same author

Prediction of COVID-19 mortality using machine learning strategies and a large-scale panel of plasma inflammatory proteins: A cohort study.

Medicina intensiva·2025
Same author

Association of systemic inflammation and long-term dysfunction in COVID-19 patients: A prospective cohort.

Psychoneuroendocrinology·2025
Same author

Identification of distinct phenotypes and improving prognosis using metabolic biomarkers in COVID-19 patients.

Critical care science·2024
Same author

The epileptic heart: Cardiac comorbidities and complications of epilepsy. Atrial and ventricular structure and function by echocardiography in individuals with epilepsy - From clinical implications to individualized assessment.

Epilepsy & behavior reports·2024
Same author

Detection of seizures with ictal tachycardia, using heart rate variability and patient adaptive logistic regression machine learning methods: A hospital-based validation study.

Epileptic disorders : international epilepsy journal with videotape·2024

相关实验视频

Updated: Jun 7, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

868

对于酒精使用障碍的大麻素.

Júlia Dalfovo Marquez1, Talissa Dezanetti1, Roger Walz2

  • 1Programa de Pós-Graduação em Neurociências, Universidade Federal de Santa Catarina (UFSC), Florianópolis, Brazil.

International review of neurobiology
|November 10, 2024
PubMed
概括

大麻和酒精结合可能会带来风险,但大麻素化合物显示出治疗酒精使用障碍 (AUD) 的潜力. 研究探讨了这种组合在AUD治疗中的好处和危害.

关键词:
禁欲 禁欲 禁欲 禁欲 禁欲吸毒成 吸毒成 是一种成.酒精饮料 酒精饮料 酒精饮料 酒精饮料酒精使用障碍 饮酒障碍这是一种大麻素 (cannabinoid).大麻大麻大麻大麻大麻大麻大麻渴望的渴望 渴望的渴望大麻大麻是一种大麻.替代疗法是一种替代疗法.

更多相关视频

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

7.9K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.1K

相关实验视频

Last Updated: Jun 7, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

868
Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

7.9K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.1K

科学领域:

  • 神经科学是一个神经科学.
  • 药理学 药理学是指药理学的学科.
  • 成 药物 药物 药物 药物

背景情况:

  • 内分泌大麻素系统影响大脑的奖励路径和药物滥用.
  • 大麻素受体 (CB1和CB2) 可能调节成性质.
  • 大麻和酒精经常被共同使用,这可能对酒精使用障碍 (AUD) 有潜在的影响.

研究的目的:

  • 审查有关酒精和大麻结合的益处和风险的证据.
  • 探索大麻素化合物对AUD的治疗潜力.
  • 为了应对因合法化而日益增加的大麻可用性.

主要方法:

  • 关于大麻,酒精和内分泌系统的现有研究的文献综述.
  • 对酒精和大麻的共同使用研究的分析.
  • 检查关于AUD的大麻素治疗方法的临床前和临床数据.

主要成果:

  • 一些证据表明,大麻可能有助于AUD治疗,作为替代药物.
  • 同时使用酒精和大麻可以增加不良结果的风险.
  • 大麻素化合物是有前途的,但与联合使用相关的风险需要仔细考虑.

结论:

  • 酒精和大麻的结合提供了潜在的治疗途径和AUD的重大风险.
  • 需要进一步的研究来澄清大麻素在AUD治疗中的确切作用,并减轻联合使用的风险.
  • 基于大麻素的疗法需要对AUD进行调查,平衡潜在的益处与已知的风险.